Koelis, a prostate cancer-focused firm, has announced a new partnership with DeepHealth for artificial intelligence (AI)-powered prostate MRI interpretation and guidance in fusion biopsy.
Under the collaboration, DeepHealth Prostate software will be integrated with the Koelis Trinity 3D Ultrasound Platform.
The integration is expected to improve the MRI reading process and enable prostate fusion biopsy and treatment.
DeepHealth, a wholly owned subsidiary of RadNet, is a provider of AI-driven radiology informatics, including large-scale cancer screening programmes.
Images processed through DeepHealth’s clinical imaging workspace can be transferred to the Koelis Trinity platform for 3D MRI/US fusion procedures.
Lenox Hill Radiology, New York City medical director Dr John Melnick said: “We have been offering Koelis fusion biopsy at Lenox Hill Radiology since 2020.
“As the director of prostate imaging, I have been reading and preparing all MRI prior to fusion biopsy.”
The Koelis Trinity system is designed to allow urologists to conduct 3D targeted fusion biopsies for prostate cancer. It combines 3D ultrasound imaging with MRI-US fusion guidance.
This system features proprietary prostate motion tracking software (OBT Fusion).
According to France-based Koelis, its compact design eliminates the need for external ultrasound equipment or sensors. It also enables more accurate biopsy diagnoses and offers less invasive treatment options.
In May, Koelis announced several new updates to the Trinity system including a new Promap Contour software.
Koelis founder and CEO Antoine Leroy said: “Always responding and innovating to meet the needs of urologists and their patients, Koelis is excited about announcing this enhancement in the Radiology/AI field as well as on our flagship application the transperineal fusion biopsy.
“We strongly believe that our collaboration with DeepHealth will facilitate the adoption of MRI fusion biopsy as a new standard of care in the USA. We are committed to continuously improving our product offering.”
The latest partnership will allow urologists and radiologists to collaborate and improve workflow efficiencies in the prostate cancer clinical pathway.
It will also enable PACS/cloud connectivity and automated MRI segmentation for easy integration into the Koelis Trinity platform, said the prostate cancer-focused company.
This system will use the imaging data to generate a 3D, patient-specific prostate map. Koelis said that this map will guide both diagnostic and treatment procedures. Recently, DeepHealth signed a data and development partnership with HOPPR to advance AI in the healthcare sector.
